Evidence map›Paper›PMID 24878334›Full record

ArticleAnalytical biochemistry2014

A fluorescence-based assay to monitor autopalmitoylation of zDHHC proteins applicable to high-throughput screening.

Laura D Hamel, Robert J Deschenes, David A Mitchell

Open access · greenAbstract read
In one paragraph

Article in Analytical biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Biochemistry · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Open biology · 2022
    Review
  10. Article
  11. Insights into auto-RSC chemical biology · 2021
    Review
  12. Inhibitors of DHHC family proteins.Current opinion in chemical biology · 2021
    Review
  13. Article
  14. Article
  15. The Journal of biological chemistry · 2019
    Article
  16. Article
  17. cat-ELCCA: catalyzing drug discovery through click chemistry.Chemical communications (Cambridge, England) · 2018
    Article
  18. Article
  19. Article
  20. Identification of Protein Palmitoylation Inhibitors from a Scaffold Ranking Library.Combinatorial chemistry & high throughput screening · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Laura D HamelDepartment of Molecular Medicine, University of South Florida, Tampa, FL 33612, USA.
Robert J DeschenesDepartment of Molecular Medicine, University of South Florida, Tampa, FL 33612, USA.
David A MitchellDepartment of Molecular Medicine, University of South Florida, Tampa, FL 33612, USA. Electronic address: dmitchel@health.usf.edu.
University of South Florida · US

Funding

STRUCTURAL CHANGES AND THE FUNCTION OF RAS ONCOGENESR01CA050211 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI DESCHENES, ROBERT J · 1990 to 2010
$2.2M
Endomembrane Targeting and Signaling of RAS ProteinsR01GM073977 · NIGMS · UNIVERSITY OF SOUTH FLORIDA · PI DESCHENES, ROBERT J · 2008 to 2011
$1.1M
Protein Palmitoylation and the Etiology of X-Linked Intellectual DisabilitiesR21NS090160 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI DESCHENES, ROBERT J · 2016 to 2017
$411k
NCI NIH HHS CA050211NCI NIH HHS R01 CA050211NIGMS NIH HHS GM073977NIGMS NIH HHS R01 GM073977NINDS NIH HHS R21 NS090160
6 · The paper itself

Abstract

Palmitoylation, the posttranslational thioester-linked modification of a 16-carbon saturated fatty acid onto the cysteine residue of a protein, has garnered considerable attention due to its implication in a multitude of disease states. The signature DHHC motif (Asp-His-His-Cys) identifies a family of protein acyltransferases (PATs) that catalyze the S-palmitoylation of target proteins via a two-step mechanism. In the first step, autopalmitoylation, palmitate is transferred from palmitoyl-CoA to the PAT, creating a palmitoyl:PAT intermediate and releasing reduced CoA. The palmitoyl moiety is then transferred to a protein substrate in the second step of the reaction. We have developed an in vitro, single-well, fluorescence-based enzyme assay that monitors the first step of the PAT reaction by coupling the production of reduced CoA to the reduction of NAD(+) using the α-ketoglutarate dehydrogenase complex. This assay is suitable for determining PAT kinetic parameters, elucidating lipid donor specificity and measuring PAT inhibition by 2-bromopalmitate. Finally, it can be used for high-throughput screening (HTS) campaigns for modulators of protein palmitoylation.

Indexed as

LipoylationAcyltransferasesAmino Acid MotifsCoenzyme ADetergentsEnzyme AssaysHigh-Throughput Screening AssaysKineticsLipid MetabolismMembrane ProteinsOxidation-ReductionPalmitatesSaccharomyces cerevisiae ProteinsSpectrometry, FluorescenceSubstrate Specificity2-bromopalmitateAcyltransferasesCoenzyme ADetergentsERF2 protein, S cerevisiaeMembrane ProteinsPalmitatesSaccharomyces cerevisiae ProteinsSHR5 protein, S cerevisiaeAutopalmitoylationHigh-throughput screeningPosttranslational modificationProtein palmitoylationzDHHC proteins

Identifiers

PMID24878334
PMCPMC6445550
OpenAlexW2037008902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.